lansoprazole has been researched along with Duodenal Reflux in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Duodenogastric reflux is known to cause an increased frequency of cancer in the glandular portion of the stomach in rats." | 1.32 | Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. ( Maartmann-Moe, H; Viste, A; Waldum, H; Øvrebø, K, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viste, A | 1 |
| Øvrebø, K | 1 |
| Maartmann-Moe, H | 1 |
| Waldum, H | 1 |
1 other study available for lansoprazole and Duodenal Reflux
| Article | Year |
|---|---|
Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Administration, Oral; Animals; Duodenogastr | 2004 |